XML 26 R46.htm IDEA: XBRL DOCUMENT v2.4.0.6
Share-based compensation plans (Tables)
12 Months Ended
Dec. 31, 2012
Schedule of Share-Based Compensation by Line Item in Condensed Consolidated Statements of Operations

The following table shows the detail of share-based compensation by line item in the consolidated statements of operations for the years ended December 31, 2012, 2011 and 2010 and the assumptions for each of these years in which grants were awarded:

 

(US$ in thousands, except assumptions)

   Year Ended
December 31,
2012
    Year Ended
December 31,
2011
    Year Ended
December 31,
2010 (1)
 

Cost of sales

   $ 592      $ 153      $ 210   

Sales and marketing

     1,550        2,031        3,505   

General and administrative

     4,023        4,322        4,105   

Research and development

     138        142        318   
  

 

 

   

 

 

   

 

 

 

Total

   $ 6,303      $ 6,648      $ 8,138   
  

 

 

   

 

 

   

 

 

 
Schedule of Stock Option Activity

Summaries of the status of the Company’s stock option plans as of December 31, 2012 and 2011 and changes during the year ended December 31, 2012 are presented below:

 

     Options     Weighted Average
Exercise Price
     Weighted
Average
Remaining
Contractual
Term
 

Outstanding at December 31, 2011

     2,559,272      $ 33.41      

Granted

     347,250      $ 40.46      

Exercised

     (716,564   $ 31.50      

Forfeited

     (244,003   $ 40.50      
  

 

 

      

Outstanding at December 31, 2012

     1,945,955      $ 34.50         5.39   
  

 

 

      

Vested and expected to vest at December 31, 2012

     1,903,616      $ 34.42         5.31   
  

 

 

      

Options exercisable at December 31, 2012

     1,448,293           4.20   
  

 

 

      
Schedule of Stock Options Outstanding and Exercisable by Price Range

Outstanding and exercisable by price range as of December 31, 2012

 

     Options Outstanding      Options Exercisable  

Range of Exercise Prices

   Number
Outstanding
     Weighted
Average
Remaining
Contractual
Life
     Weighted
Average
Exercise
Price
     Number
Exercisable
     Weighted
Average
Exercise
Price
 

$10.42 – $25.01

     253,661         5.09       $ 23.40         253,661       $ 23.40   

$25.05 – $28.95

     326,383         5.30       $ 26.96         314,383       $ 26.97   

$29.23 – $33.01

     314,433         6.84       $ 31.60         167,102       $ 31.44   

$33.08 – $38.11

     347,859         3.50       $ 37.49         307,194       $ 37.51   

$38.40 – $39.94

     282,687         6.61       $ 39.68         126,687       $ 39.69   

$40.27 – $41.37

     210,000         7.05       $ 41.22         68,334       $ 41.20   

$43.04 – $45.84

     188,932         3.47       $ 44.63         188,932       $ 44.63   

$50.15 – $50.15

     12,500         4.29       $ 50.15         12,500       $ 50.15   

$50.50 – $50.50

     2,000         4.01       $ 50.50         2,000       $ 50.50   

$50.99 – $50.99

     7,500         4.04       $ 50.99         7,500       $ 50.99   
  

 

 

          

 

 

    

$10.42 – $50.99

     1,945,955         5.39       $ 34.50         1,448,293       $ 33.54   
  

 

 

          

 

 

    
Schedule of Changes in Restricted Stock
     Shares     Weighted
Average Grant
Date Fair Value
 

Non-vested as of December 31, 2011

     69,000      $ 29.23   

Granted

     149,500      $ 40.93   

Vested

     (28,336   $ 29.23   

Cancelled

     (29,333   $ 38.87   
  

 

 

   

Non-vested as of December 31, 2012

     160,831      $ 38.34